Nulojix (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02500498 (ClinicalTrials.gov) | October 2014 | 15/7/2015 | Safety Profile of Nulojix in Home Infusion Settings | Safety Profile of Nulojix in Home Infusion Settings | Rheumatoid Arthritis | Drug: Nulojix | Bristol-Myers Squibb | BiologicTx, LLC | Completed | 18 Years | N/A | Both | 37 | N/A | NULL |